Literature DB >> 25281025

Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma.

Alice C Johnston1, Kikkeri Naresh, Tara Barwick, Philippa May, Anastasios Karadimitris, Holger W Auner.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25281025     DOI： 10.1007/s00277-014-2226-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

1.  Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D.

Authors:  Duncan M Gascoyne; Linden Lyne; Hayley Spearman; Francesca M Buffa; Elizabeth J Soilleux; Alison H Banham
Journal:  Endocrinology       Date:  2017-03-01       Impact factor: 4.736

2.  Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy.

Authors:  Tongjuan Li; Jiaqi Tan; Liting Chen; Dong Kuang; Xia Mao; Yaoyao Lou; Jianfeng Zhou; Xiaoxi Zhou
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.